BacteriologyCHROMagar™ ESBL/mSuperCARBA bi-plate medium for detection of ESBL- and carbapenemase-producing Enterobacteriaceae from spiked stools
Section snippets
Acknowledgments
We thank Saoussen Oueslati and Sandrine Bernabeu for helping constituting the panel of isolates.
Funding
This work was partially supported by the University Paris-Sud, France and Assistance Publique-Hôpitaux de Paris, Paris, France. LD, DG, and TN are members of the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT) supported by a grant from the French National Research Agency (ANR-10-LABX-33).
Transparency declaration
None to declare.
References (19)
- et al.
Project management: importance for diagnostic laboratories
Clin Microbiol Infect
(2017) - et al.
Laboratory automation in clinical bacteriology: what system to choose?
Clin Microbiol Infect
(2016) - et al.
CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens
Diagn Microbiol Infect Dis
(2017) - et al.
CHROMagar mSuperCARBA and RAPIDEC® Carba NP test for detection of carbapenemase-producing Enterobacteriaceae
Diagn Microbiol Infect Dis
(2018) - et al.
Chromogenic culture media or rapid immunochromatographic test: which is better for detecting Klebsiella pneumoniae that produce OXA-48 and can they be used in blood and urine specimens
J Microbiol Methods
(2018) - et al.
Automation in bacteriology: a changing way to perform clinical diagnosis in infectious diseases
Clin Microbiol Infect
(2016) - et al.
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Trends Mol Med
(2012) - et al.
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Lancet Infect Dis
(2008) - et al.
Review: Molecular detection of extended spectrum-beta-lactamase– and carbapenemase-producing Enterobacteriaceae in a clinical setting
Diagn Microbiol Infect Dis
(2017)
Cited by (13)
A European multicenter evaluation study to investigate the performance on commercially available selective agar plates for the detection of carbapenemase producing Enterobacteriaceae
2022, Journal of Microbiological MethodsCitation Excerpt :As both these CPE-groups are the most common in human clinical settings and are the ones that primarily have been detected in food or animals (Bonardi and Pitino, 2019). Several studies have already been conducted on evaluating the performance of different CPE selective agar media (Cohen Stuart et al., 2013; Garcia-Fernandez et al., 2017; Girlich et al., 2013a; Girlich et al., 2013b; Girlich et al., 2019; Gottig et al., 2020). However, to our knowledge, no cross-country multicenter studies have been performed, nor a study including all commercially available selective agar plates on the market.